Showing results (51-60 of 141) with videos related to

Sort By:
Pageof 15
The Journal of Clinical Endocrinology and Metabolism|September 11, 2012
PTEN lipid phosphatase activity and proper subcellular localization are necessary and sufficient for down-regulating AKT phosphorylation in the nucleus in Cowden syndromeXin He, Motoyasu Saji, Deepa Radhakrishnan, et al.
The Journal of Clinical Endocrinology and Metabolism|August 11, 2020
Features of Cytologically Indeterminate Molecularly Benign Nodules Treated With SurgeryMayumi Endo, Kyle Porter, Clarine Long, et al.
European Journal of Endocrinology|December 14, 2004
Thyroid follicular adenomas may display features of follicular carcinoma and follicular variant of papillary carcinomaVasily V Vasko, Jean Gaudart, Claude Allasia, et al.
Thyroid : Official Journal of the American Thyroid Association|March 23, 2011
Frequency of germline PTEN mutations in differentiated thyroid cancerRebecca Nagy, Shireen Ganapathi, Ilene Comeras, et al.
Biochemical and Biophysical Research Communications|July 31, 2002
Paternal imprinting of Galpha(s) in the human thyroid as the basis of TSH resistance in pseudohypoparathyroidism type 1aEmily L Germain-Lee, Chang Lin Ding, Zhichao Deng, et al.
Thyroid : Official Journal of the American Thyroid Association|September 18, 2012
In thyroidectomized patients with thyroid cancer, a serum thyrotropin of 30 μU/mL after thyroxine withdrawal is not always adequate for detecting an elevated stimulated serum thyroglobulinLaticia A Valle, Revital L Gorodeski Baskin, Kyle Porter, et al.
Thyroid : Official Journal of the American Thyroid Association|April 12, 2022
Serum Thyroglobulin Measurement Following Surgery Without Radioactive Iodine for Differentiated Thyroid Cancer: A Systematic ReviewRoger Chou, Tracy Dana, Gregory A Brent, et al.
Surgery|November 10, 2015
Integrin-linked kinase affects signaling pathways and migration in thyroid cancer cells and is a potential therapeutic targetLawrence A Shirley, Samantha McCarty, Ming-Chen Yang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 16, 2019
KRAS G12V Mutation in Acquired Resistance to Combined BRAF and MEK Inhibition in Papillary Thyroid CancerDwight H Owen, Bhavana Konda, Jennifer Sipos, et al.
Pageof 15